Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CNR1 | P21554 | 6/20 | 0.49 |
| ▸ | CNR2 | P34972 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4562967 | 0.92 | CNR1 (0.44) | KMT2ACNR1CNR2MEN1POLB | |
| SCHEMBL3683921 | 0.92 | KMT2A (0.52) | KMT2ACNR1CNR2MEN1HSD11B1 | |
| SCHEMBL4562966 | 0.87 | KMT2A (0.49) | KMT2ACNR1CNR2MEN1HSD11B1 | |
| SCHEMBL4563366 | 0.84 | KMT2A (0.54) | KMT2ACNR1CNR2MEN1HSD11B1 | |
| SCHEMBL4563669 | 0.83 | CNR1 (0.46) | KMT2ACNR1CNR2MEN1HSD11B1 | |
| SCHEMBL4563605 | 0.82 | KMT2A (0.47) | KMT2ACNR1CNR2MEN1HSD11B1 | |
| SCHEMBL12064374 | 0.76 | CNR1 (0.47) | KMT2ACNR1CNR2MEN1HSD11B1 | |
| SCHEMBL4563346 | 0.74 | KMT2A (0.47) | KMT2ACNR1CNR2MEN1HSD11B1 | |
| SCHEMBL5141889 | 0.74 | CNR1 (0.50) | KMT2ACNR1CNR2MEN1HSD11B1 | |
| SCHEMBL12064305 | 0.73 | POLB (0.43) | KMT2ACNR1CNR2MEN1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2026798-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CBX CANNABINOID RECEPTOR MODULATORS AND POTASSIUM CHANNEL MODULATORS | Solvay Pharmaceuticals GmbH (DE) | 2009-02-25 | — | — | EP | disclosed |
| WO-2007125048-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CBX CANNABINOID RECEPTOR MODULATORS AND POTASSIUM CHANNEL MODULATORS | SOLVAY PHARMACEUTICALS GMBH (DE) | 2007-11-08 | — | — | WO | disclosed |